Avid Bioservices, Inc.
Avid Bioservices, Inc. (CDMO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CDMO · as of Dec 31, 2024
Ownership Breakdown
204
Institutional Holders
▲ 28 vs Q3
$838.97M
Total Inst. Value
▲ $65.03M vs Q3
63.96M
Shares Outstanding
freeFloat 79.67%
67.93M
13F Shares Held
▼ 89,196 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CDMO largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 5.26M | 8.24% | 8.24% | $64.99B | Feb 7, 2025 | ▲ 3.0K |
ALTRAVUE CAPITAL, LLC pharmaceutical preparations | 3.80M | 5.95% | 5.95% | $46.90B | Feb 12, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 3.77M | 5.91% | 5.91% | $46.57B | Feb 11, 2025 | ▼ 75.3K |
GLAZER CAPITAL, LLC pharmaceutical preparations | 3.72M | 5.82% | 5.82% | $45.91B | Feb 14, 2025 | NEW |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. pharmaceutical preparations | 2.88M | 4.52% | 4.52% | $35.62B | Feb 14, 2025 | ▼ 49.4K |
STATE STREET CORP pharmaceutical preparations | 2.67M | 4.19% | 4.19% | $33.02B | Feb 14, 2025 | ▼ 328.9K |
FIL LTD pharmaceutical preparations | 2.56M | 4.01% | 4.01% | $31.60B | Feb 13, 2025 | NEW |
ROYAL BANK OF CANADA pharmaceutical preparations | 2.51M | 3.93% | 3.93% | $30.96B | Feb 14, 2025 | ▼ 321.1K |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 1.95M | 3.06% | 3.06% | $24.10B | Feb 11, 2025 | ▲ 1.48M |
ALPINE ASSOCIATES MANAGEMENT INC. pharmaceutical preparations | 1.95M | 3.05% | 3.05% | $24.03B | Feb 7, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
10
Increased
+5.23M shares20
New Positions
first time holders17
Decreased
−9.22M shares0
Sold Out
fully exitedNet shares change (top 50)
3.98M
+5.23M / −9.22M
Net new holders
+13
20 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CDMO insider trading · insider activity
Source: SEC Form 4
2
Buy transactions
77
Sell transactions
0.03
Buy/Sell ratio
$3M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 14,286 | $9.17 | $131.0K | 174.9K | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 21,429 | $3.50 | $75.0K | 153.4K | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 1,733 | — | — | 108.6K | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 98,120 | $6.07 | $595.6K | 55.3K | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 17,679 | — | — | 51.4K | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 51,413 | — | — | 0 | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 55,310 | $6.95 | $384.4K | 0 | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 108,579 | — | — | 0 | Form 4 ↗ |
Ziebell Mark R V. P., General Counsel | Feb 5, 2025 | D-Return | 66,799 | — | — | 0 | Form 4 ↗ |
Thoma Jeanne director | Feb 5, 2025 | D-Return | 45,611 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Avid Bioservices, Inc. (CDMO) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 20.33%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Avid Bioservices, Inc. is BLACKROCK, INC., holding approximately 5.26 million shares — equal to 8.24% of outstanding shares — as of December 31, 2024.
A total of 204 institutional investors currently hold CDMO stock, with a combined institutional value of approximately $838,972,420 as of the most recent 13F filing period.
Frequently asked questions
CDMO ownershipAvid Bioservices, Inc. (CDMO) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 8.24% stake. Company insiders hold 20.33%. Data sourced from SEC Form 13F as of December 31, 2024.